These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17941886)

  • 1. Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome.
    Wieland I; Weidner C; Ciccone R; Lapi E; McDonald-McGinn D; Kress W; Jakubiczka S; Collmann H; Zuffardi O; Zackai E; Wieacker P
    Clin Genet; 2007 Dec; 72(6):506-16. PubMed ID: 17941886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the phenotype of craniofrontonasal syndrome: two unrelated boys with EFNB1 mutations and congenital diaphragmatic hernia.
    Vasudevan PC; Twigg SR; Mulliken JB; Cook JA; Quarrell OW; Wilkie AO
    Eur J Hum Genet; 2006 Jul; 14(7):884-7. PubMed ID: 16639408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel EFNB1 mutation in a patient with craniofrontonasal syndrome and right hallux duplication.
    Seven M; Gezdirici A; Ulucan H; Karatas OF; Yosunkaya E; Yuksel A; Ozen M
    Gene; 2013 Sep; 527(2):675-8. PubMed ID: 23845783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant cell segregation in the craniofacial primordium and the emergence of facial dysmorphology in craniofrontonasal syndrome.
    Niethamer TK; Teng T; Franco M; Du YX; Percival CJ; Bush JO
    PLoS Genet; 2020 Feb; 16(2):e1008300. PubMed ID: 32092051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of a family with craniofrontonasal syndrome.
    Özylmaz B; Gezdirici A; Özen M; Kalenderer Ö
    Clin Dysmorphol; 2015 Apr; 24(2):79-83. PubMed ID: 25486017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic.
    Wieland I; Makarov R; Reardon W; Tinschert S; Goldenberg A; Thierry P; Wieacker P
    Eur J Hum Genet; 2008 Feb; 16(2):184-91. PubMed ID: 18043713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craniofrontonasal syndrome in a male due to chromosomal mosaicism involving EFNB1: further insights into a genetic paradox.
    Evers C; Jungwirth MS; Morgenthaler J; Hinderhofer K; Maas B; Janssen JW; Jauch A; Hehr U; Steinbeisser H; Moog U
    Clin Genet; 2014 Apr; 85(4):347-53. PubMed ID: 23614707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS).
    Wieland I; Reardon W; Jakubiczka S; Franco B; Kress W; Vincent-Delorme C; Thierry P; Edwards M; König R; Rusu C; Schweiger S; Thompson E; Tinschert S; Stewart F; Wieacker P
    Hum Mutat; 2005 Aug; 26(2):113-8. PubMed ID: 15959873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes.
    Twigg SR; Babbs C; van den Elzen ME; Goriely A; Taylor S; McGowan SJ; Giannoulatou E; Lonie L; Ragoussis J; Sadighi Akha E; Knight SJ; Zechi-Ceide RM; Hoogeboom JA; Pober BR; Toriello HV; Wall SA; Rita Passos-Bueno M; Brunner HG; Mathijssen IM; Wilkie AO
    Hum Mol Genet; 2013 Apr; 22(8):1654-62. PubMed ID: 23335590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel de novo mutation within EFNB1 gene in a young girl with craniofrontonasal syndrome.
    Apostolopoulou D; Stratoudakis A; Hatzaki A; Kaxira OS; Panagopoulos KP; Kollia P; Aleporou V
    Cleft Palate Craniofac J; 2012 Jan; 49(1):109-13. PubMed ID: 21385071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four novel mutations in EFNB1 in Indian patients with craniofrontonasal syndrome.
    Howaldt A; Nampoothiri S; Yesodharan D; Udayakumaran S; Subash P; Kornak U
    J Hum Genet; 2019 Sep; 64(9):867-873. PubMed ID: 31285555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe craniofrontonasal syndrome in a male patient mosaic for a novel nonsense mutation in EFNB1.
    Shotelersuk V; Kamolvisit W; Rojvachiranonda N; Suphapeetiporn K; Porntaveetus T; Shotelersuk V
    Eur J Med Genet; 2020 Jun; 63(6):103924. PubMed ID: 32240825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome.
    Twigg SR; Kan R; Babbs C; Bochukova EG; Robertson SP; Wall SA; Morriss-Kay GM; Wilkie AO
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8652-7. PubMed ID: 15166289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of craniofrontonasal syndrome: new symptoms and novel pathogenic variants in the EFNB1 gene.
    Bukowska-Olech E; Gawliński P; Jakubiuk-Tomaszuk A; Jędrzejowska M; Obersztyn E; Piechota M; Bielska M; Jamsheer A
    Orphanet J Rare Dis; 2021 Jun; 16(1):286. PubMed ID: 34174922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome.
    Wieland I; Jakubiczka S; Muschke P; Cohen M; Thiele H; Gerlach KL; Adams RH; Wieacker P
    Am J Hum Genet; 2004 Jun; 74(6):1209-15. PubMed ID: 15124102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFNB1 mutation at the ephrin ligand-receptor dimerization interface in a patient with craniofrontonasal syndrome.
    Torii C; Izumi K; Nakajima H; Takahashi T; Kosaki K
    Congenit Anom (Kyoto); 2007 Mar; 47(1):49-52. PubMed ID: 17300690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Korean Patients with Craniofrontonasal Syndrome Confirmed by EFNB1 Analysis.
    Yoo H; Ko JM; Lim BC; Cheong HI
    Ann Clin Lab Sci; 2016 Sep; 46(5):544-8. PubMed ID: 27650623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males.
    Twigg SR; Matsumoto K; Kidd AM; Goriely A; Taylor IB; Fisher RB; Hoogeboom AJ; Mathijssen IM; Lourenco MT; Morton JE; Sweeney E; Wilson LC; Brunner HG; Mulliken JB; Wall SA; Wilkie AO
    Am J Hum Genet; 2006 Jun; 78(6):999-1010. PubMed ID: 16685650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance.
    Al-Owain M; Kaya N; Al-Zaidan H; Al-Hashmi N; Al-Bakheet A; Al-Muhaizea M; Chedrawi A; Basran RK; Milunsky A
    Clin Genet; 2011 Apr; 79(4):363-70. PubMed ID: 20528889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the OPHN1 gene detected by aCGH.
    Madrigal I; Rodríguez-Revenga L; Badenas C; Sánchez A; Milà M
    J Intellect Disabil Res; 2008 Mar; 52(Pt 3):190-4. PubMed ID: 18261018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.